IL-5 Inhibitors (Severe Asthma)
IL-5 is the signal that tells eosinophils — a type of white blood cell — to grow and survive. In severe eosinophilic asthma those cells flood the airways and drive attacks. Blocking IL-5, or the receptor it binds to, strips the eosinophils out and can roughly halve the rate of asthma exacerbations in people whose disease is not controlled by inhalers alone.
2 IL-5 Inhibitors in this directory
Compare IL-5 Inhibitors side by side
Browse other drug classes
How this page is built
The facts on this page are pulled directly from official U.S. FDA datasets — they are not written from memory. Each field below names the dataset it came from, so you can check it yourself.
- FDA Drug Label (openFDA) ↗ Indications, mechanism of action and pharmacologic class
- Drugs@FDA ↗ First FDA approval date and the company holding the application
- FDA Drug Shortage Database ↗ Current US supply / shortage status
Plain-English summaries and drug-class explainers are written and reviewed by Sreepriya Prasannan (MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany). Data is retrieved automatically from the sources above and cross-checked with AI-assisted verification (Anthropic's Claude) — brand and generic names are matched against the exact FDA product record so that a combination product or a different formulation cannot be mistaken for the drug on this page. An editor reviews the result before publication. We describe this in full in our editorial standards and corrections policy. The FDA data on this page was last retrieved on 13 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.